SAFEXIM CV (Cefixime (200mg) + Clavulanic Acid (125mg))

Safexim CV is an antibiotic formulation that combines Cefixime at a dosage of 200 mg with Potassium Clavulanate at 125 mg. This combination is specifically designed to effectively combat a variety of bacterial infections. Cefixime belongs to the class of broad-spectrum cephalosporins, which are well-known for their ability to target a diverse range of both gram-positive and gram-negative bacteria. The addition of Potassium Clavulanate serves to enhance the overall effectiveness of the treatment by inhibiting the action of beta-lactamase enzymes that are often produced by bacteria that exhibit resistance to other antibiotics. This makes Safexim CV particularly beneficial in managing infections of the respiratory system, urinary tract, as well as skin infections. As a result, it stands out as a dependable option for comprehensive management of various bacterial infections, ensuring that patients receive effective therapy tailored to their needs. Use this medicine only under medical supervision. Follow the dose and schedule exactly as advised. Do not stop abruptly without guidance. Keep a record of any unusual symptoms and share them with your clinician. Combine therapy with appropriate lifestyle measures and routine monitoring as recommended. Use this medicine only under medical supervision. Follow the dose and schedule exactly as advised. Do not stop abruptly without guidance. Keep a record of any unusual symptoms and share them with your clinician. Combine therapy with appropriate lifestyle measures and routine monitoring as recommended.